2 weeks Amgen stock falls as analysts mull over weight loss drug’s bone density dataCNBC

Analysts cited data from a phase one study showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.

Amgen (AMGN)

2 days Why Amgen (AMGN) is a Top Value Stock for the Long-TermZacks X

5 days Amgen Sells Off: Keep Calm And Buy The DipSeeking Alpha X

6 days Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on ItZacks X

1 week 2 Reasons to Buy Amgen Stock, and 1 Reason to Be CautiousThe Motley Fool X

1 week Amgen, Merck stocks dive as Trump picks anti-vaxxer RFK Jr. to lead US healthcareFXStreet X

1 week Amgen Shrugs Off Bone Density Concerns Related to Obesity CandidateZacks X

1 week Amgen Inc. (AMGN) UBS Global Healthcare Conference (Transcript)Seeking Alpha X

2 weeks Trade Tracker: Joe Terranova sells Amgen and buys XBIYouTube X

2 weeks Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?Investor's Business Daily X

2 weeks Amgen dismisses bone density concerns related to its new weight-loss drugInvesting.com X

2 weeks Amgen sinks as Cantor flags issues with obesity drugYouTube X

2 weeks Amgen Drops 7% After A ‘Big Unknown Risk’ Rattles Its Monthly Obesity ShotInvestor's Business Daily X

3 weeks Big Pharma’s Obesity Bonanza Faces New TestsThe Wall Street Journal X

3 weeks Amgen: A Biotech Giant Offering Value And Growth In A Frothy MarketSeeking Alpha X

3 weeks Analyst Report: AMGEN Inc.Yahoo Finance X

3 weeks Market Digest: AAPL, AMGN, AMP, BBY, CTSH, EPD, MCO, UNP, MA, VRSK, PPC, GEHCYahoo Finance X

3 weeks Amgen Inc. (AMGN) Q3 2024 Earnings Call TranscriptSeeking Alpha X

3 weeks Amgen Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X

3 weeks Amgen (AMGN) Q3 2024 Earnings Call TranscriptThe Motley Fool X

3 weeks Amgen ‘Laser-Focused’ On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFOInvestor's Business Daily X

3 weeks Amgen beats Q3 earnings estimates, raises full-year guidanceInvesting.com X

4 weeks Pfizer Unveils Its Next Black Box In Obesity. It’s Taking On Amgen.Investor's Business Daily X

4 weeks First American Bank Has $4.18 Million Stake in Amgen Inc. (NASDAQ:AMGN)MarketBeat X

4 weeks Zacks Research Forecasts Amgen’s Q1 Earnings (NASDAQ:AMGN)MarketBeat X

4 weeks Amgen Inc. Declares Quarterly Dividend of $2.25 (NASDAQ:AMGN)MarketBeat X

4 weeks Amgen Q3 Earnings Review: So Many Questions, But MariTide Data Top Of The ListSeeking Alpha X

1 month Amgen Gears Up to Report Q3 Earnings: Here’s What to ExpectZacks X

1 month Allspring Global Investments Holdings LLC Sells 11,091 Shares of Amgen Inc. (NASDAQ:AMGN)MarketBeat X

1 month Amgen (NASDAQ:AMGN) Stock Rating Reaffirmed by Cantor FitzgeraldMarketBeat X

1 month Amgen Inc. (NASDAQ:AMGN) Shares Sold by Raleigh Capital Management Inc.MarketBeat X

1 month Why Amgen (AMGN) Dipped More Than Broader Market TodayZacks X

1 month Amgen (NASDAQ:AMGN) Price Target Raised to $383.00MarketBeat X

1 month Penn Davis Mcfarland Inc. Raises Stake in Amgen Inc. (NASDAQ:AMGN)MarketBeat X

1 month Creative Planning Has $63.40 Million Stock Position in Amgen Inc. (NASDAQ:AMGN)MarketBeat X

1 month Raymond James & Associates Sells 71,201 Shares of Amgen Inc. (NASDAQ:AMGN)MarketBeat X

More news +